Home » Drug Information » Recently Approved Drugs » 1996
Medical Areas: Musculoskeletal | Neurology | Oncology
Drug Information
The following information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
Company: Purepac Pharmaceutical
Approval Status: Approved July 1996
Treatment Area: chronic pain
Kadian, a single daily dosage sustained-release morphine
product, has been approved by the FDA. Kadian provides relief for
chronic moderate to severe pain (pain related to cancer), and has
been demonstrated to be as effective when taken once a day as
conventional morphine products taken every four hours.
